Showing results (291-300 of 408) with videos related to

Sort By:
Pageof 41
Statistical Methods in Medical Research|April 9, 2024
Methods for non-proportional hazards in clinical trials: A systematic reviewMaximilian Bardo, Cynthia Huber, Norbert Benda, et al.
Nature Medicine|May 10, 2026
The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trialJohann Bauersachs, Scott D Solomon, Stefan D Anker, et al.
Age and Ageing|May 24, 2024
Evaluating palliative care case conferences in primary care for patients with advanced non-malignant chronic conditions: a cluster-randomised controlled trial (KOPAL)Tina Mallon, Josefine Schulze, Judith Dams, et al.
Annals of Palliative Medicine|October 23, 2023
Cost-effectiveness of a specialist palliative care nurse-patient consultation followed by an interprofessional case conference for patients with non-oncological palliative care needs: results of the KOPAL trialSophie Gottschalk, Hans-Helmut König, Tina Mallon, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 5, 2023
Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trialUrsula Rauch-Kröhnert, Marianna Puccini, Marius Placzek, et al.
Neurology|September 3, 2013
Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohortBrit Mollenhauer, Ellen Trautmann, Friederike Sixel-Döring, et al.
Cost Effectiveness and Resource Allocation : C/E|April 13, 2024
Health economic evaluation of blended collaborative care for older multimorbid heart failure patients: study protocolLisa Derendorf, Stephanie Stock, Dusan Simic, et al.
Pharmaceutical Statistics|November 21, 2018
On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapiesSteffen Unkel, Marjan Amiri, Norbert Benda, et al.
The Lancet. Diabetes & Endocrinology|May 20, 2024
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysisMuhammad Shariq Usman, Deepak L Bhatt, Ishaque Hameed, et al.
ESC Heart Failure|February 19, 2026
Baseline characteristics in the TransitionCHF study: asymptomatic patients with heart failure and reduced ejection fractionIrina Müller-Kozarez, Anja Sandek, Frank Edelmann, et al.
Pageof 41